How much is the current market price of sparsentan/sparsentan per box?

Sparsentan/Sparsentan is currently not available in the domestic market, so it cannot be purchased directly in the domestic market. Since the drug has not yet been approved in China, there is no pricing and medical insurance reimbursement information for sparsentan on the market. For patients, if they need to use sparsentane, they usually need to purchase it through imported drugs or overseas channels. The price of sparsentane in overseas markets is relatively high, especially in the European market. Usually, a box of 200mg30 tablets or 400mg30 tablets of the original drug may cost more than 40,000 yuan (the specific price will vary according to exchange rate changes).

This high price is mainly due to the fact that sparsentan, as a new type of kidney disease treatment drug, has great appeal in terms of its effectiveness and market demand in treating primary immunoglobulin A nephropathy (IgAN). However, as the drug market gradually develops, especially with the introduction of generic drugs, prices are likely to fall.

In overseas markets, in addition to original drugs, there are also some generic pharmaceutical products. For example, a generic version of sparsentan produced by a pharmaceutical factory in Laos has a specification of 400mg*30 tablets, and each box sells for about more than 3,000 yuan. Compared with original drugs, the price of generic drugs is obviously more affordable, but it is still affected by exchange rate fluctuations.

Although Sparsentan has not yet been launched in China, its price may be adjusted in the future as the international market promotion and related approvals advance. Especially after it is approved in the Chinese market and included in medical insurance, the financial burden on patients may be effectively alleviated. As the market matures, the introduction of generic versions may provide more economical options for patients who require sparsentane.

Reference materials:https://www.sparsentan.com/